Literature DB >> 2689754

Citrate: a major factor in the toxicity of orally administered aluminum compounds.

B A Molitoris, D H Froment, T A Mackenzie, W H Huffer, A C Alfrey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2689754     DOI： 10.1038/ki.1989.286

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  10 in total

Review 1.  Hyperphosphataemia in renal failure: causes, consequences and current management.

Authors:  Fouad Albaaj; Alastair Hutchison
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

3.  Potentiation of aluminium absorption by effervescent analgesic tablets in a haemodialysis patient.

Authors:  J Main; M K Ward
Journal:  BMJ       Date:  1992-06-27

4.  Preventing bone disease requires diligent management in patients with renal failure.

Authors:  F O Kolb
Journal:  West J Med       Date:  1994-05

5.  The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.

Authors:  Peter N Van Buren; Julia B Lewis; Jamie P Dwyer; Tom Greene; John Middleton; Mohammed Sika; Kausik Umanath; Josephine D Abraham; Shahabul S Arfeen; Isai G Bowline; Gil Chernin; Stephen Z Fadem; Simin Goral; Mark Koury; Marvin V Sinsakul; Daniel E Weiner
Journal:  Am J Kidney Dis       Date:  2015-05-07       Impact factor: 8.860

Review 6.  Citric Acid: A Multifunctional Pharmaceutical Excipient.

Authors:  Maria Lambros; Thac Henry Tran; Qinqin Fei; Mike Nicolaou
Journal:  Pharmaceutics       Date:  2022-04-30       Impact factor: 6.525

Review 7.  Managing hyperphosphatemia in patients with chronic kidney disease on dialysis with ferric citrate: latest evidence and clinical usefulness.

Authors:  Yoram Yagil; Stephen Z Fadem; Kotagal S Kant; Udayan Bhatt; Mohammed Sika; Julia B Lewis; Dana Negoi
Journal:  Ther Adv Chronic Dis       Date:  2015-09       Impact factor: 5.091

Review 8.  Secondary hyperparathyroidism in children with chronic renal failure: pathogenesis and treatment.

Authors:  Cheryl P Sanchez
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 9.  Safety of new phosphate binders for chronic renal failure.

Authors:  Mahmoud Loghman-Adham
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

10.  Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice?

Authors:  David W Mudge; David W Johnson; Carmel M Hawley; Scott B Campbell; Nicole M Isbel; Carolyn L van Eps; James J B Petrie
Journal:  BMC Nephrol       Date:  2011-05-13       Impact factor: 2.388
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.